C16orf89 Protein (Transcript Variant 1) (Myc-DYKDDDDK Tag)
This Recombinant C16orf89 protein is produced in HEK-293 Cells.
1 image
Catalog No. ABIN2718585
Quick Overview for C16orf89 Protein (Transcript Variant 1) (Myc-DYKDDDDK Tag) (ABIN2718585)
Target
C16orf89
(Chromosome 16 Open Reading Frame 89 (C16orf89))
Protein Type
Recombinant
Origin
Human
Source
HEK-293 Cells
Application
Antibody Production (AbP), Standard (STD)
Purity
> 80 % as determined by SDS-PAGE and Coomassie blue staining
-
-
Protein Characteristics
- Transcript Variant 1
-
Purification tag / Conjugate
- This C16orf89 protein is labelled with Myc-DYKDDDDK Tag.
-
Characteristics
-
- Recombinant human Chromosome 16 open reading frame 89 (C16orf89), transcript variant 1 (transcript variant 1) protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
-
-
Application Notes
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays -
Comment
-
The tag is located at the C-terminal.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 50 μg/mL
-
Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
-
Storage
- -80 °C
-
Storage Comment
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
-
- C16orf89 (Chromosome 16 Open Reading Frame 89 (C16orf89))
-
Background
- This gene is expressed predominantly in the thyroid. Based on expression patterns similar to thyroid transcription factors and proteins, this gene may function in the development and function of the thyroid. Multiple transcript variants encoding different isoforms have been found for this gene.
-
Molecular Weight
- 49.2 kDa
-
NCBI Accession
- NP_689672
Target
-
You are here:
